Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

被引：3
|
作者：
Nagueh, SF [1 ]
Lakkis, NM [1 ]
Middleton, KJ [1 ]
Franklin, J [1 ]
Spencer, WH [1 ]
机构：
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
来源：
CIRCULATION | 2004年 / 109卷 / 05期
关键词：
D O I：
10.1161/01.CIR.0000115644.35804.8B
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E27 / E28
页数：2
相关论文
共 50 条
  • [41] Reoperation Was an Effective Therapy in Patients with Obstructive Hypertrophic Cardiomyopathy After Septal Reduction Therapy
    Zhang, Yang
    Zhu, Changsheng
    Song, Changpeng
    Yin, Kunlun
    Zhang, Jian
    Huang, Manyun
    Zheng, Xinxin
    Lu, Jie
    Fang, Xiaonan
    Zhou, Zhou
    Wang Shuiyun
    Huang, Xiaohong
    CIRCULATION, 2021, 144
  • [42] Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy
    Dimitrow, PP
    Podolec, P
    Grodecki, J
    Plazak, W
    Dudek, D
    Pieniazek, P
    Bacior, B
    Legutko, J
    Olszowska, M
    Kostkiewicz, M
    Kawecka-Jaszcz, K
    Tracz, W
    Dubiel, JS
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 94 (01) : 31 - 34
  • [43] Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
    Desai, Milind Y.
    Owens, Anjali
    Geske, Jeffrey B.
    Wolski, Kathy
    Naidu, Srihari S.
    Smedira, Nicholas G.
    Cremer, Paul C.
    Schaff, Hartzell
    McErlean, Ellen
    Sewell, Christina
    Li, Wanying
    Sterling, Lulu
    Lampl, Kathy
    Edelberg, Jay M.
    Sehnert, Amy J.
    Nissen, Steven E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (02) : 95 - 108
  • [44] Contemporary Septal Reduction Therapy in Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
    Maekawa, Yuichiro
    Akita, Keitaro
    Takanashi, Shuichiro
    CIRCULATION JOURNAL, 2018, 82 (08) : 1977 - 1984
  • [45] COSTS OF SEPTAL REDUCTION THERAPY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: A US CLAIMS ANALYSIS
    Butzner, M.
    Sarocco, P.
    Maron, M.
    Rowin, E.
    Teng, C. C.
    Stanek, E.
    Tan, H.
    Robertson, L.
    VALUE IN HEALTH, 2021, 24 : S73 - S73
  • [46] Myocardial 3-Dimensional Printing for Septal Myectomy Guidance in a Patient With Obstructive Hypertrophic Cardiomyopathy
    Yang, Dong Hyun
    Kang, Joon-Won
    Kim, Namkug
    Song, Jae-Kwan
    Lee, Jae-Won
    Lim, Tae-Hwan
    CIRCULATION, 2015, 132 (04) : 300 - 301
  • [47] IMPACT OF PULMONARY HYPERTENSION ON SEPTAL REDUCTION THERAPY OUTCOMES FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Isath, Ameesh
    Lanier, Gregg M.
    Spielvogel, David
    Malekan, Ramin
    Steinmetz, Carolyn
    Semaan, Rosa
    Fishkin, Tzvi
    Panza, Julio A.
    Naidu, Srihari S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 549 - 549
  • [48] Non-surgical reduction of septal myocardial mass in a patient with hypertrophic obstructive cardiomyopathy
    Fusegawa, Y
    Abe, S
    Sakakibara, M
    Handa, S
    INTERNAL MEDICINE, 1999, 38 (07) : 585 - 589
  • [49] Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Evaluation by contrast-enhanced magnetic resonance imaging
    van Dockum, WG
    ten Cate, FJ
    ten Berg, JM
    Beek, AM
    Twisk, JWR
    Vos, J
    Hofman, MBM
    Visser, CA
    van Rossum, AC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (01) : 27 - 34
  • [50] Decreased expression of turner necrosis factor-α and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Stetson, SJ
    Lakkis, NM
    Killip, D
    Perez-Verdia, A
    Entman, ML
    Spencer, WH
    Torre-Amione, G
    CIRCULATION, 2001, 103 (14) : 1844 - 1850
12345